The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

lab21.com

Stage

Divestiture

Total Raised

$16.74M

Investors Count

9

Deal Terms

2

Portfolio Exits

2

Lab21 Funding, Lab21 Valuation & Lab21 Revenue

8 Fundings

Lab21's latest funding round was a Acquired for on June 5, 2014.

Lab21's valuation in August 2010 was $30M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

6/5/2014

Acquired

0

FY undefined

1

7/9/2012

Growth Equity

$99M

0

FY undefined

0

2/20/2012

Series A

0

FY undefined

0

8/17/2010

Angel - II

$99M

$30M

0

FY undefined

0

9/7/2009

Seed

$99M

0

FY undefined

0

Date

6/5/2014

7/9/2012

2/20/2012

8/17/2010

9/7/2009

Round

Acquired

Growth Equity

Series A

Angel - II

Seed

Amount

$99M

$99M

$99M

Investors

Valuation

$30M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

0

0

0

0

Lab21 Deal Terms

2 Deal Terms

Lab21's deal structure is available for 2 funding rounds, including their Angel - II from August 17, 2010.

Round

Angel - II

Angel

Funding Date

$99M

$99M

Pre-Money Valuation

$99M

$99M

Post-Money Valuation

$99M

$99M

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Angel - II

$99M

$99M

$99M

$99M

$99M

$99M

Angel

$99M

$99M

$99M

$99M

$99M

$99M

Lab21 Investors

9 Investors

Lab21 has 9 investors. Novacyt invested in Lab21's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

6/5/2014

6/5/2014

1
Acquired

Corporation

France

00/00/0000

00/00/0000

Clydesdale Bank

Subscribe to see more

Bank

United Kingdom

00/00/0000

00/00/0000

Upstate Carolina Angel Network

Subscribe to see more

Angel Investor (Group)

South Carolina

00/00/0000

00/00/0000

Nexus Medical Partners

Subscribe to see more

Private Equity

Massachusetts

00/00/0000

00/00/0000

SC Launch

Subscribe to see more

Government

South Carolina

First funding

6/5/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

6/5/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Clydesdale Bank

Upstate Carolina Angel Network

Nexus Medical Partners

SC Launch

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Bank

Angel Investor (Group)

Private Equity

Government

Location

France

United Kingdom

South Carolina

Massachusetts

South Carolina

Lab21 Acquisitions

1 Acquisition

Lab21 acquired 1 company. Their latest acquisition was Selah Genomics on December 18, 2009.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

12/18/2009

Debt

$99M

$0.75M

Acquired

1

Date

12/18/2009

Investment Stage

Debt

Companies

Valuation

$99M

Total Funding

$0.75M

Note

Acquired

Sources

1

Lab21 Portfolio Exits

2 Portfolio Exits

Lab21 has 2 portfolio exits. Their latest portfolio exit was Lab21 - Blood Bank Screening Business on October 22, 2013.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/22/2013

Divestiture

$99M

1

1/9/2013

Management Buyout

Subscribe to see more

Subscribe to see more

10

Date

10/22/2013

1/9/2013

Exit

Divestiture

Management Buyout

Companies

Subscribe to see more

Valuation

$99M

Acquirer

Subscribe to see more

Sources

1

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.